Detalhe da pesquisa
1.
The socioeconomic distribution of life expectancy and healthy life expectancy in Chile.
Int J Equity Health
; 22(1): 160, 2023 08 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-37608366
2.
Economic evaluation of a multimorbidity patient centered care model implemented in the Chilean public health system.
BMC Health Serv Res
; 23(1): 1041, 2023 Sep 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-37773153
3.
[The expected cost of cancer in Chile]. / El costo esperado de cáncer en Chile.
Rev Med Chil
; 150(11): 1438-1449, 2022 Nov.
Artigo
em Espanhol
| MEDLINE | ID: mdl-37358169
4.
Prevalence, burden of disease, and lost in health state utilities attributable to chronic musculoskeletal disorders and pain in Chile.
BMC Public Health
; 21(1): 937, 2021 05 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-34001042
5.
Cost-Effectiveness of Mepolizumab Add-On in the Treatment of Severe Eosinophilic Asthma in Chile.
Value Health Reg Issues
; 35: 69-77, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-36889021
6.
Cost-effectiveness analysis: fluticasone furoate/umeclidinium/vilanterol for the treatment of moderate to severe chronic obstructive pulmonary disease from the perspective of the Chilean public health system.
Expert Rev Pharmacoecon Outcomes Res
; 22(5): 743-751, 2022 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-35176212
7.
Health and economic effects on patients with type 2 diabetes mellitus in the long run: predictions for the Chilean population.
Diabetol Metab Syndr
; 14(1): 155, 2022 Oct 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-36289521
8.
Cost analysis of chronic pain due to musculoskeletal disorders in Chile.
PLoS One
; 17(10): e0273667, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36301984
9.
El costo esperado de cáncer en Chile / The expected cost of cancer in Chile
Rev. méd. Chile
; 150(11): 1438-1449, nov. 2022. ilus, tab, graf
Artigo
em Espanhol
| LILACS | ID: biblio-1442051